Team I am a biopharma entrepreneur with a PhD in Biotechnology from the University of Cambridge, and I have built and exited high-impact ventures across the full therapeutics value chain. As founding CEO of Cape Biotech, I deployed a ~$100m government-backed venture programme, leading investments including Kapa Biosystems, which achieved a ~$450m acquisition by Roche (~100x return), one of the most significant biotech exits in South Africa’s history. I subsequently founded Vx Pharma, scaling it into a profitable clinical research site network delivering Phase I–III trials for all top 10 global pharmaceutical companies across >100 studies, before successfully selling its South African operations. I later repositioned Vx Pharma (UK) into an advisory and venture studio focused on risk-based clinical development models and decentralised clinical trial platforms. Earlier in my career, I drove award-winning innovation at FirstRand Bank, pioneering a novel risk-sharing pricing model that transfor